2.4 semaglutide Trial designs for SUSTAIN 2-4 and 10 It is used for weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater Order WEGOVY® FLEXTOUCH® 2.4mg (Italian)

Probiotics: supporting the gut microbiome Changes in gut motility and digestion affect the microbiome

Potential Positives Omada Health's Enhanced GLP-1 Care Track demonstrated that members experienced significantly greater weight loss compared to industry benchmarks, with an average weight loss of 18.4% for those who persisted in the program for 12 months

(3) Fielding R, et al

W., Muckenthaler, M

Early Morning Awakening Some users find themselves waking earlier than intended during the first weeks of treatment

doi: 10.3389/fendo.2021.738848 Received 09 July 2021 Accepted 30 September 2021 Published 21 October 2021 Volume 12 - 2021 Edited by Vinod Tiwari, Indian Institute of Technology (BHU), India Reviewed by Jan Danser, Erasmus Medical Center, Netherlands